EUVIMEDEUVIMED entdecken
Crossref

Integrated network pharmacology and molecular simulation analysis of colchicine in coronary in-stent restenosis

Suryono Suryono, Muhammad I. Amien, Achmad I. Tohari, Antonius D. Saputra, Muhammad R. Fahrudin Hidayat, Muhammad N. Hibatullah, Hazbina F. Ramadhan, Muhammad F. Hibatulloh

Journal of Pharmacy & Pharmacognosy Research · 01.07.2026 · 14 (4) · 2545

DOI: 10.56499/jppres_14.4.2545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.07.2026. Verfasst von Suryono Suryono und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

In-stent restenosis (ISR) remains a major complication following percutaneous coronary intervention. Increasing evidence suggests that genetic and inflammatory mechanisms contribute to ISR pathogenesis. Colchicine has demonstrated anti-inflammatory effects in cardiovascular diseases; however, its molecular targets in ISR remain unclear.

Aims

To identify potential molecular targets and signaling pathways through which colchicine may modulate ISR using integrated computational approaches.

Methods

ISR-related genes were retrieved from GeneCards, OMIM, and CTD databases. Colchicine targets were predicted using SwissTargetPrediction, BindingDB, SEASearch, and DrugBank. Overlapping genes were analyzed using protein–protein interaction networks and hub gene identification. Functional enrichment analysis was performed using GO and KEGG pathways. Molecular docking and 200 ns molecular dynamics simulations were conducted to evaluate binding stability. Binding free energies were calculated using MM-GBSA.

Results

Sixteen overlapping targets were identified, and ten hub genes were prioritized. Docking analysis demonstrated moderate binding affinity of colchicine toward CYP3A4, TUBB1, and CYP2B6 (−6.9 to −7.4 kcal/mol). Molecular dynamics simulations indicated stable ligand–protein complexes with RMSD values below 2.5 Å. MM-GBSA analysis suggested favorable binding energies, particularly for TUBB1.

Conclusions

Colchicine was predicted to interact with several ISR-associated targets and pathways, providing a computational basis for further experimental validation.

Zitieren

APA

Suryono, S., Amien, M. I., Tohari, A. I., Saputra, A. D., Hidayat, M. R. F., Hibatullah, M. N., Ramadhan, H. F., & Hibatulloh, M. F. (2026). Integrated network pharmacology and molecular simulation analysis of colchicine in coronary in-stent restenosis. Journal of Pharmacy & Pharmacognosy Research, 14(4), 2545. https://doi.org/10.56499/jppres_14.4.2545

Vancouver

Suryono S, Amien MI, Tohari AI, Saputra AD, Hidayat MRF, Hibatullah MN, et al. Integrated network pharmacology and molecular simulation analysis of colchicine in coronary in-stent restenosis. Journal of Pharmacy & Pharmacognosy Research. 2026;14(4):2545. doi:10.56499/jppres_14.4.2545

BibTeX
@article{Suryono2026,
  author = {Suryono, Suryono and Amien, Muhammad I. and Tohari, Achmad I. and Saputra, Antonius D. and Hidayat, Muhammad R. Fahrudin and Hibatullah, Muhammad N. and Ramadhan, Hazbina F. and Hibatulloh, Muhammad F.},
  title = {Integrated network pharmacology and molecular simulation analysis of colchicine in coronary in-stent restenosis},
  journal = {Journal of Pharmacy & Pharmacognosy Research},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {2545},
  doi = {10.56499/jppres_14.4.2545}
}
Kostenlos starten →